Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
May 2022	50	Global Markets Direct	ASDR-601538

Published: May 2022 - Pages : 50 - Publisher : Global Markets Direct - Report code : ASDR-601538

AgeneBio Inc
Cerevel Therapeutics Holdings Inc
F. Hoffmann-La Roche Ltd
Les Laboratoires Servier SAS
Ono Pharmaceutical Co Ltd
Saniona AB